SCHEMBL7374175

SCHEMBL7374175

NNC1NCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11685202 0.97
SCHEMBL17224702 0.87
SCHEMBL4747699 0.64
SCHEMBL3540492 0.58
SCHEMBL28198320 0.56
SCHEMBL660984 0.54
SCHEMBL11103590 0.54
SCHEMBL13227939 0.54
SCHEMBL7558516 0.54
SCHEMBL1073021 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101248092-B Functionalized polymers and tires improved therefrom BRIDGESTONE CORP 2012-12-05 CN claimed
CN-101248092-A Functionalized polymers and tires improved therefrom BRIDGESTONE CORP (JP) 2008-08-20 CN claimed
CN-101084235-A 3-deoxyglucosone and skin DYNAMIS THERAPEUTICS INC (US) 2007-12-05 CN claimed
CN-1990477-A Linear dicationic terphenyls and their aza analogues as antiparasitic agents UNIV NORTH CAROLINA CHAPEL HILL (US) 2007-07-04 CN claimed
EP-3950673-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF Inspirna, Inc. (US) 2022-02-09 EP disclosed
EP-3137447-B1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF RGENIX INC (US) 2021-06-30 EP disclosed
US-10717704-B2 Inhibitors of creatine transport and uses thereof RGENIX, INC. (US) 2020-07-21 US disclosed
US-20190315680-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF INSPIRNA, INC. 2019-10-17 US disclosed
US-10308597-B2 Inhibitors of creatine transport and uses thereof RGENIX, INC. (US) 2019-06-04 US disclosed
EP-3137447-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF Rgenix, Inc. (US) 2017-03-08 EP disclosed
US-20170050924-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF INSPIRNA, INC. 2017-02-23 US disclosed
WO-2016176636-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF RGENIX, INC. (US) 2016-11-03 WO disclosed
CN-1090178-C Tricyclic compounds having activity specific for integrins, in particular alpha v beta 3 integrins, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them HOECHST MARION ROUSSEL INC (FR) 2002-09-04 CN disclosed
CN-1305492-A Pyrazinone protease inhibitors DIMENSIONAL PHARM INC (US) 2001-07-25 CN disclosed
CN-1303365-A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors DIMENSIONAL PHARM INC (US) 2001-07-11 CN disclosed
CN-1284084-A Echinocandin derivatives, their preparation and their use as antifungal agents HOECHST MARION ROUSSEL INC (FR) 2001-02-14 CN disclosed
CN-1237961-A Aminoguanidines and alkoxyguanidines as protease inhibitors DIMENSIONAL PHARM INC (US) 1999-12-08 CN disclosed
CN-1219165-A Tricyclic compounds having activity specific for integrins, in particular alpha v beta 3 integrins, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them HOECHST MARION ROUSSEL CO (FR) 1999-06-09 CN disclosed
WO-1996026190-A1 INTEGRIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1996-08-29 WO disclosed
CN-1050023-A The method for preparing cephalosporin derivative BEECHAM GROUP PLC (GB) 1991-03-20 CN disclosed